163 related articles for article (PubMed ID: 19147071)
21. Peripheral blood or bone marrow as hematopoietic stem cell source for autologous transplantation in acute myeloid leukemia?
Ferrara F; Palmieri S; Mele G
J Clin Oncol; 2010 May; 28(15):e246-7; author reply e248-9. PubMed ID: 20368550
[No Abstract] [Full Text] [Related]
22. Is there a role for consolidation therapy pre-transplantation?
Rowe JM
Best Pract Res Clin Haematol; 2006; 19(2):301-10. PubMed ID: 16516127
[TBL] [Abstract][Full Text] [Related]
23. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
[TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.
Mannis GN; Martin TG; Damon LE; Logan AC; Olin RL; Flanders MD; Ai WZ; Gaensler KM; Kaplan LD; Sayre PH; Smith CC; Wolf JL; Andreadis C
Leuk Lymphoma; 2016 Jul; 57(7):1560-6. PubMed ID: 26490487
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukemia with concurrent myeloid sarcoma treated with autologous bone marrow transplantation: two illustrative cases and a literature review.
Finnegan DP; Jones FG; McMullin MF
Hematol Oncol; 2005; 23(3-4):133-5. PubMed ID: 16273593
[TBL] [Abstract][Full Text] [Related]
26. Should autologous or allogeneic stem-cell therapy be a part of consolidation therapy for all cases of adult acute myelogenous leukemia?
Garcia-Manero G; Schuster SJ; Agha ME
Semin Oncol; 1999 Feb; 26(1):xvi-xvii, xxi-xxii. PubMed ID: 10073556
[No Abstract] [Full Text] [Related]
27. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality.
Meijer E; Cornelissen JJ
Semin Oncol; 2008 Aug; 35(4):449-57. PubMed ID: 18692695
[TBL] [Abstract][Full Text] [Related]
29. Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital.
Ngamkiatphaisan S; Sriratanaban J; Kamolratanakul P; Intragumtornchai T; Noppakun N; Jongudomsuk P
J Med Assoc Thai; 2007 Dec; 90(12):2565-73. PubMed ID: 18386705
[TBL] [Abstract][Full Text] [Related]
30. The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.
Gratwohl A; Baldomero H; Schwendener A; Rocha V; Apperley J; Frauendorfer K; Niederwieser D; ;
Bone Marrow Transplant; 2009 Feb; 43(4):275-91. PubMed ID: 19169283
[TBL] [Abstract][Full Text] [Related]
31. [Autologous hematopoietic stem cell transplantation].
Nemet D
Acta Med Croatica; 2009 Jun; 63(3):219-25. PubMed ID: 19827349
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of acute leukemia with allogeneic stem cell transplantation].
Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
[TBL] [Abstract][Full Text] [Related]
33. [The autotransplantation of hemopoietic progenitors in acute myeloblastic leukemia].
Sierra Gil J; Brunet Mauri S
Med Clin (Barc); 1997 Feb; 108(6):221-3. PubMed ID: 9102488
[No Abstract] [Full Text] [Related]
34. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission.
Larson RA
Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):11-6. PubMed ID: 19147070
[TBL] [Abstract][Full Text] [Related]
36. Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Ringdén O; Labopin M; Ehninger G; Niederwieser D; Olsson R; Basara N; Finke J; Schwerdtfeger R; Eder M; Bunjes D; Gorin NC; Mohty M; Rocha V
J Clin Oncol; 2009 Sep; 27(27):4570-7. PubMed ID: 19652066
[TBL] [Abstract][Full Text] [Related]
37. Adult stem cell treatment of scleroderma.
Tyndall A; Furst DE
Curr Opin Rheumatol; 2007 Nov; 19(6):604-10. PubMed ID: 17917542
[TBL] [Abstract][Full Text] [Related]
38. Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.
Tsukimoto I; Tawa A; Horibe K; Tabuchi K; Kigasawa H; Tsuchida M; Yabe H; Nakayama H; Kudo K; Kobayashi R; Hamamoto K; Imaizumi M; Morimoto A; Tsuchiya S; Hanada R
J Clin Oncol; 2009 Aug; 27(24):4007-13. PubMed ID: 19620491
[TBL] [Abstract][Full Text] [Related]
39. Leukemia burden and outcome of allogeneic transplant in acute myelogenous leukemia.
Kamble RT; Hjortsvang E; Selby GB
Biol Blood Marrow Transplant; 2006 Jun; 12(6):691-2. PubMed ID: 16737944
[No Abstract] [Full Text] [Related]
40. Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML.
Kim HJ; Min WS; Cho BS; Eom KS; Kim SY; Kim YJ; Lee S; Min CK; Cho SG; Lee JW; Kim CC
Bone Marrow Transplant; 2009 Sep; 44(6):345-51. PubMed ID: 19270728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
